Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;50(5):1089-1100.
doi: 10.1016/j.semarthrit.2020.06.015. Epub 2020 Jun 30.

Advances in our understanding of gout as an auto-inflammatory disease

Shari Bodofsky  1 , Tony R Merriman  2 , T J Thomas  3 , Naomi Schlesinger  3
Affiliations
Review

Advances in our understanding of gout as an auto-inflammatory disease

Shari Bodofsky et al. Semin Arthritis Rheum. 2020 Oct.

Abstract

Gout, the most common inflammatory arthritis, is the result of hyperuricemia and inflammation induced by monosodium urate (MSU) crystal deposition. However, most people with hyperuricemia will never develop gout, implying a molecular-genetic contribution to the development of gout. Recent genomic studies reveal links between certain genetic variations and gout. We highlight recent advances in our understanding of gout as an auto-inflammatory disease. We review the auto-inflammatory aspects of gout, including the inflammasome and thirteen gout-associated inflammatory-pathway genes and associated comorbidities. This information provides important insights into emerging immune-modulating targets in the management of gout, and future novel therapeutic targets in gout treatment. Cumulatively, this has important implications for treating gout as an auto-inflammatory disease, as opposed to a purely metabolic disease.

Keywords: Autoinflammatory; Genetic; Gout; Inflammasome; Molecular.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest TRM Research grant funding from Ardea Biosciences and Ironwood Pharmaceuticals and consulting fees from Ironwood Pharmaceuticals. Grants: Pfizer, AMGEN; Advisory boards and consulting Horizon Pharma, IFM Therapeutics, Johnson and Johnson.

LinkOut - more resources